Emerging biomarkers in ischemic stroke

Abstract

Ischemic stroke is a devastating global public health problem and the leading cause of acute death and chronic disability. Despite being the diagnostic cornerstone, limitations in neuroimaging, including availability, cost, and therapeutic window, have rekindled interest in biomarker-based approaches. Biomarkers will be employed to facilitate the eventual prediction, early diagnosis, and prognosis of strokes, as well as to inform person-centered medicine. This review summarizes recent advances in the search for biomarkers related to inflammatory, endothelial, metabolic, and neuroaxonal pathways. Interleukin-6 (IL-6), asymmetric dimethylarginine (ADMA), endothelial microparticles (EMP), and homocysteine serve as predictive biomarkers corresponding to vascular risk and inflammatory priming. Glial fibrillary acidic protein (GFAP), D-dimer, and neuron-specific enolase (NSE) are diagnostic markers that can already subtype stroke and estimate lesion burden. Prognostic biomarkers, such as serum neurofilament light chain (sNfL), N-terminal pro-B-type natriuretic peptide (NT-pro-BNP), and growth differentiation factor 15 (GDF-15), are associated with infarct size and long-term outcomes. The -omic sciences (genomic, proteomic, and metabolomic) have discovered defined molecular signatures and panels with high specificity to describe heterogeneity in stroke. Cerebrospinal fluid (CSF) biomarkers and newer imaging modalities, such as those provided through positron emission tomography/computed tomography (PET/CT), offer valuable adjuncts to blood biomarkers in the diagnosis of conditions. Translational potential is hindered by heterogeneity in the transcriptional landscape.

Keywords

Ischemic stroke / cerebral ischemia / biomarkers / omics

References

[1] Virani SS,Aparicio HJ.Heart disease and stroke statistics-2021 update: a report from the American Heart Association.Circulation2021;143:e254-743

[2] Tsao CW,Almarzooq ZI.Heart disease and stroke statistics-2022 update: a report from the American Heart Association.Circulation2022;145:e153-639

[3] Pu L,Zhang R,Jiang Y.Projected global trends in ischemic stroke incidence, deaths and disability-adjusted life years from 2020 to 2030.Stroke2023;54:1330-9

[4] Iadecola C,Anrather J.Immune responses to stroke: mechanisms, modulation, and therapeutic potential.J Clin Invest2020;130:2777-88 PMCID:PMC7260029

[5] Mokin M,Siddiqui AH.ASPECTS (Alberta Stroke Program Early CT Score) measurement using hounsfield unit values when selecting patients for stroke thrombectomy.Stroke2017;48:1574-9

[6] Gasull T.Molecular Mechanisms and Pathophysiology of Acute Stroke: Emphasis on Biomarkers in the Different Stroke Subtypes.Int J Mol Sci2022;23:9476 PMCID:PMC9409332

[7] Rathburn CM,Sharma LK.TOAST stroke subtype classification in clinical practice: implications for the get with the guidelines-stroke nationwide registry.Front Neurol2024;15:1375547 PMCID:PMC10995393

[8] Nam KW,Lee YS.Clinical significance of D-dimer levels during acute period in ischemic stroke.Thromb J2023;21:55 PMCID:PMC10170762

[9] Jiménez MC,Glynn RJ,Gaziano JM.Association between high-sensitivity C-reactive protein and total stroke by hypertensive status among men.J Am Heart Assoc2015;4:e002073

[10] Ridker PM.Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease.Circ Res2021;128:1728-46

[11] Ballantyne CM,Bang H.Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.Arch Intern Med2005;165:2479-84

[12] Ridker PM,Thuren T.Antiinflammatory therapy with canakinumab for atherosclerotic disease.N Engl J Med2017;377:1119-31

[13] Ballantyne CM,Bang H.Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.Circulation2004;109:837-42

[14] Durrani Y,Murphy D.Prospective validation of glial fibrillary acidic protein, d‐dimer, and clinical scales for acute large‐vessel occlusion ischemic stroke detection.SVIN2024;4:e001304

[15] Akbar M,Tammasse J,Aulina S.Plasma D-dimer as a biomarker for the early classification of common acute ischemic stroke subtypes in Indonesia.Egypt J Neurol Psychiatry Neurosurg2023;59:720

[16] Albers GW,Kemp S.Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging.N Engl J Med2018;378:708-18

[17] Campbell BCV,Ringleb PA.Extending thrombolysis to 4·5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data.Lancet2019;394:139-47

[18] Jickling GC,Ander BP.Profiles of lacunar and nonlacunar stroke.Ann Neurol2011;70:477-85

[19] Vaughn A,Prodan CI.Do Commonly Obtained Laboratory Data Differ between Lacunar and Non-Lacunar Strokes in the Acute Setting?.Neurology2013;80:P03.185

[20] Armario P,Garcia-Sanchez SM.Differences in biomarkers levels and brachial and central blood pressure during the acute phase of stroke between lacunar and other ischemic strokes subtypes.J Hypertens2018;36:e27

[21] Arboix A,García-Eroles L,Comes E.Clinical predictors of lacunar syndrome not due to lacunar infarction.BMC Neurol2010;10:31 PMCID:PMC2877662

[22] Zhao YH,Pan ZY.Prognostic value of NT-proBNP after ischemic stroke: a systematic review and meta-analysis of prospective cohort studies.J Stroke Cerebrovasc Dis2020;29:104659

[23] Sanchez JD,Mun KT.Temporal patterning of neurofilament light as a blood-based biomarker for stroke: a systematic review and meta-analysis.Front Neurol2022;13:841898 PMCID:PMC9149427

[24] Venter JC,Myers EW.The sequence of the human genome.Science2001;291:1304-51

[25] Aebersold R.Mass spectrometry-based proteomics.Nature2003;422:198-207

[26] Kim TJ,Kim YJ,Han D.Proteomic analyses of clots identify stroke etiologies in patients undergoing endovascular therapy.CNS Neurosci Ther2025;31:e70340

[27] Doche E,Guigonis JM.How clot composition influences fibrinolysis in the acute phase of stroke: a proteomic study of cerebral thrombi.Stroke2024;55:1818-29

[28] Dawson J,Delles C,Mullen W.Urinary proteomics to support diagnosis of stroke.PLoS One2012;7:e35879 PMCID:PMC3353991

[29] Patti GJ,Siuzdak G.Innovation: metabolomics: the apogee of the omics trilogy.Nat Rev Mol Cell Biol2012;13:263-9 PMCID:PMC3682684

[30] Karmelić I,Starčević K.Comparative targeted metabolomics of ischemic stroke: thrombi and serum profiling for the identification of stroke-related metabolites.Biomedicines2024;12:1731 PMCID:PMC11351249

[31] Papadopoulos A,Björkbacka H.Circulating interleukin-6 levels and incident ischemic stroke: a systematic review and meta-analysis of prospective studies.Neurology2022;98:e1002-12

[32] Blecharz-Lang KG,Fries A.Interleukin 6-mediated endothelial barrier disturbances can be attenuated by blockade of the IL6 receptor expressed in brain microvascular endothelial cells.Transl Stroke Res2018;9:631-42

[33] Xue Y,Tu WJ.Tumor necrosis factor-α: the next marker of stroke.Dis Markers2022;2022:2395269 PMCID:PMC8898850

[34] Xu G,Su L.The role and therapeutic potential of nuclear factor κB (NF-κB) in ischemic stroke.Biomed Pharmacother2024;171:116140

[35] Lip GY,Hughes E.High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis.Stroke2007;38:1229-37

[36] Georgakis MK,Björkbacka H.Circulating monocyte chemoattractant protein-1 and risk of stroke: meta-analysis of population-based studies involving 17 180 individuals.Circ Res2019;125:773-82

[37] Xu Q,Tian X.Monocyte chemoattractant protein-1, inflammatory biomarkers, and prognosis of patients with ischemic stroke or transient ischemic attack: fndings from a nationwide registry study.J Am Heart Assoc2024;13:e035820 PMCID:PMC11963953

[38] Li J,Lin J.Soluble CD40L is a useful marker to predict future strokes in patients with minor stroke and transient ischemic attack.Stroke2015;46:1990-2

[39] Simak J,Yu H,Baird AE.Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome.J Thromb Haemost2006;4:1296-302

[40] Dignat-George F.The many faces of endothelial microparticles.Arterioscler Thromb Vasc Biol2011;31:27-33

[41] Sibal L,Home PD.The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease.Curr Cardiol Rev2010;6:82-90 PMCID:PMC2892080

[42] Furuki K,Matsuoka H.Plasma levels of asymmetric dimethylarginine (ADMA) are related to intima-media thickness of the carotid artery: an epidemiological study.Atherosclerosis2007;191:206-10

[43] Willeit P,Laukkanen JA.Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies.J Am Heart Assoc2015;4:e001833 PMCID:PMC4599532

[44] Yilmaz G.Cell adhesion molecules and ischemic stroke.Neurol Res2008;30:783-93 PMCID:PMC2748428

[45] Richard S,Burkhard PR,Turck N.E-selectin and vascular cell adhesion molecule-1 as biomarkers of 3-month outcome in cerebrovascular diseases.J Inflamm2015;12:61 PMCID:PMC4634720

[46] Foley KE.Soluble biomarkers of cerebrovascular pathologies.Stroke2024;55:801-11 PMCID:PMC10965230

[47] Tanne D,Boyko V.Soluble intercellular adhesion molecule-1 and risk of future ischemic stroke: a nested case-control study from the Bezafibrate Infarction Prevention (BIP) study cohort.Stroke2002;33:2182-6

[48] Wang M,Liu D.Soluble adhesion molecules and functional outcome after ischemic stroke: A Mendelian randomization study.J Stroke Cerebrovasc Dis2023;32:107136

[49] Thompson A,Orfei L.Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.Lancet2010;375:1536-44

[50] Chen F,Hu H,Deng Z.Nonlinear association of fibrinogen levels with functional prognosis in patients with acute ischemic stroke: a prospective cohort study.BMC Neurol2024;24:163 PMCID:PMC11103930

[51] Swarowska M,Pera J,Slowik A.Hyperfibrinogenemia predicts long-term risk of death after ischemic stroke.J Thromb Thrombolysis2014;38:517-21 PMCID:PMC4182591

[52] Lee SJ,Lee SE.Association of fibrinogen level with early neurological deterioration among acute ischemic stroke patients with diabetes.BMC Neurol2017;17:101 PMCID:PMC5438529

[53] Mehta V,Jyoti D.Fibrinogen as a predictor of early neurological deterioration in acute ischemic stroke - evidence from the Indian population.J Cent Nerv Syst Dis2023;15:11795735231156349 PMCID:PMC9909079

[54] Li X,Song Z.Association between fibrinogen levels and stroke-associated pneumonia in acute ischemic stroke patients.BMC Neurol2024;24:256 PMCID:PMC11267856

[55] Harris S,Kurniawan M,Hidayat R.Association of high blood homocysteine and risk of increased severity of ischemic stroke events.Int J Angiol2019;28:34-8 PMCID:PMC6417904

[56] Pinzon RT,Veronica V.The role of homocysteine levels as a risk factor of ischemic stroke events: a systematic review and meta-analysis.Front Neurol2023;14:1144584

[57] Kwon HM,Bae HJ.Homocysteine as a predictor of early neurological deterioration in acute ischemic stroke.Stroke2014;45:871-3

[58] Rabelo NN,Pipek LZ.Homocysteine is associated with higher risks of ischemic stroke: a systematic review and meta-analysis.PLoS One2022;17:e0276087 PMCID:PMC9560514

[59] Huang M,Zhou M.Lysophosphatidylcholines and phosphatidylcholines as biomarkers for stroke recovery.Front Neurol2022;13:1047101 PMCID:PMC9797831

[60] Havulinna AS,Hilvo M.Circulating ceramides predict cardiovascular outcomes in the population-based FINRISK 2002 cohort.Arterioscler Thromb Vasc Biol2016;36:2424-30

[61] Paul JF,Correia P.Serum glial fibrillary acidic protein in acute stroke: feasibility to determine stroke-type, timeline and tissue-impact.Front Neurol2024;15:1470718 PMCID:PMC11704488

[62] Guo ZN,Abuduxukuer R.Serum GFAP and UCH-L1 levels for the assessment of the absence of hemorrhagic transformation: a multicenter prospective cohort study.Stroke2025;56:22-9

[63] Luger S,Dietz A.Glial fibrillary acidic protein serum levels distinguish between intracerebral hemorrhage and cerebral ischemia in the early phase of stroke.Clin Chem2017;63:377-85

[64] Ferrari F,Ricciardi A.Quantification and prospective evaluation of serum NfL and GFAP as blood-derived biomarkers of outcome in acute ischemic stroke patients.J Cereb Blood Flow Metab2023;43:1601-11

[65] Pujol-Calderón F,Portelius E.Prediction of outcome after endovascular embolectomy in anterior circulation stroke using biomarkers.Transl Stroke Res2022;13:65-76 PMCID:PMC8766380

[66] Pandey A,Saxena K.Neuron specific enolase and c-reactive protein levels in stroke and its subtypes: correlation with degree of disability.Neurochem Res2014;39:1426-32

[67] Choi KH,Kim JM.d-dimer Level as a predictor of recurrent stroke in patients with embolic stroke of undetermined source.Stroke2021;52:2292-301

[68] Ahmad A,Manzoor Ahmad S.The correlation of D-dimer to stroke diagnosis within 24 hours: a meta-analysis.J Clin Lab Anal2022;36:e24271 PMCID:PMC8906038

[69] Zhu Z,Shi M.Plasma osteopontin levels and adverse clinical outcomes after ischemic stroke.Atherosclerosis2021;332:33-40

[70] Ozaki S,Kumon Y.Plasma thrombin-cleaved osteopontin as a potential biomarker of acute atherothrombotic ischemic stroke.Hypertens Res2017;40:61-6

[71] Sørensen SS,Carlsen AL,Bak M.Elevation of brain-enriched miRNAs in cerebrospinal fluid of patients with acute ischemic stroke.Biomark Res2017;5:24 PMCID:PMC5504978

[72] He XW,Liu YS.Increased plasma levels of miR-124-3p, miR-125b-5p and miR-192-5p are associated with outcomes in acute ischaemic stroke patients receiving thrombolysis.Atherosclerosis2019;289:36-43

[73] Montaner J,Delgado P.Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: the S100B/RAGE pathway.J Proteomics2012;75:4758-65

[74] Foerch C,Singer OC.Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion.Stroke2004;35:2160-4

[75] Bitsch A,Kemmling Y.Serum tau protein level as a marker of axonal damage in acute ischemic stroke.Eur Neurol2002;47:45-51

[76] Hesse C,Andreasen N.Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke.Neurosci Lett2001;297:187-90

[77] Srisujikul P,Tanprawate S.Serum NT-proBNP level for predicting functional outcomes after acute ischemic stroke.Sci Rep2023;13:13903 PMCID:PMC10457328

[78] Di Castelnuovo A,Costanzo S.NT-proBNP (N-terminal Pro-B-type natriuretic peptide) and the risk of stroke.Stroke2019;50:610-7

[79] Scheitz JF,Broersen LHA.High-sensitivity cardiac troponin T and recurrent vascular events after first ischemic stroke.J Am Heart Assoc2021;10:e018326

[80] Negishi K,Shimpo M,Kario K.Growth differentiation factor-15 predicts death and stroke event in outpatients with cardiovascular risk factors: the J-HOP study.J Am Heart Assoc2021;10:e022601 PMCID:PMC9075247

[81] Tiedt S,Barro C.Serum neurofilament light: a biomarker of neuroaxonal injury after ischemic stroke.Neurology2018;91:e1338-47

[82] Yilmaz G.Leukocyte recruitment and ischemic brain injury.Neuromolecular Med2010;12:193-204 PMCID:PMC2878882

[83] Yilmaz G.Impaired peripheral vascular function following ischemic stroke in mice: potential insights into blood pressure variations in the post-stroke patient.Pathophysiology2024;31:488-501 PMCID:PMC11417821

[84] Jickling GC,Ander BP,Zhan X.Targeting neutrophils in ischemic stroke: translational insights from experimental studies.J Cereb Blood Flow Metab2015;35:888-901 PMCID:PMC4640255

[85] Yilmaz G,Stokes KY.Role of T lymphocytes and interferon-gamma in ischemic stroke.Circulation2006;113:2105-12

[86] Suh B,Kwon HM.Elevated neutrophil to lymphocyte ratio and ischemic stroke risk in generally healthy adults.PLoS One2017;12:e0183706 PMCID:PMC5567907

[87] Liu D,Wang J.Association between NLR, MLR and stroke incidence, all-cause mortality among low-income aging populations: a prospective cohort study.J Inflamm Res2025;18:5715-26

[88] Lu M,Liu R,Hou B.Predictive value of neutrophil to lymphocyte ratio for ischemic stroke in patients with atrial fibrillation: A meta-analysis.Front Neurol2022;13:1029010 PMCID:PMC9792176

[89] Curtis AM,Jonas R.Endothelial microparticles: sophisticated vesicles modulating vascular function.Vasc Med2013;18:204-14

[90] Chironi GN,Simon A,Freyssinet JM.Endothelial microparticles in diseases.Cell Tissue Res2009;335:143-51

[91] Jimenez JJ,Mauro LM,Bidot CJ.Endothelial microparticles (EMP) as vascular disease markers.Adv Clin Chem2005;39:131-57

[92] Lugo-Gavidia LM,Matthews VB.Role of microparticles in cardiovascular disease: implications for endothelial dysfunction, thrombosis, and inflammation.Hypertension2021;77:1825-44

[93] Maglinger B,Frank JA.Intracranial VCAM1 at time of mechanical thrombectomy predicts ischemic stroke severity.J Neuroinflammation2021;18:109 PMCID:PMC8111916

[94] Huang Y,Huang ZX.Biomarkers and the outcomes of ischemic stroke.Front Mol Neurosci2023;16:1171101 PMCID:PMC10277488

[95] Law SH,Ke GM.Untargeted lipidomic profiling reveals lysophosphatidylcholine and ceramide as atherosclerotic risk factors in apolipoprotein E knockout mice.Int J Mol Sci2023;24:6956 PMCID:PMC10138920

[96] Azizkhanian I,Iavarone AT,Kakarla V.Plasma lipid profiling identifies biomarkers of cerebral microvascular disease.Front Neurol2019;10:950 PMCID:PMC6727208

[97] Foerch C,Back T.Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke.Clin Chem2012;58:237-45

[98] Wunderlich MT,Goertler M.Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke.J Neurol Sci2004;227:49-53

[99] Brea D,Blanco M.Temporal profile and clinical significance of serum neuron-specific enolase and S100 in ischemic and hemorrhagic stroke.Clin Chem Lab Med2009;47:1513-8

[100] Mochetti MM,Correa AAF.Neuron-specific enolase at admission as a predictor for stroke volume, severity and outcome in ischemic stroke patients: a prognostic biomarker review.Sci Rep2024;14:2688 PMCID:PMC10834412

[101] Yilmaz G,Erkuran Yilmaz C.Induction of neuro-protective/regenerative genes in stem cells infiltrating post-ischemic brain tissue.Exp Transl Stroke Med2010;2:11 PMCID:PMC2893124

[102] Tsai PC,Wang YS,Lin RT.Serum microRNA-21 and microRNA-221 as potential biomarkers for cerebrovascular disease.J Vasc Res2013;50:346-54

[103] Marchi N,Fazio V,Hallene K.Peripheral markers of blood-brain barrier damage.Clin Chim Acta2004;342:1-12

[104] Cario A.Tau, microtubule dynamics, and axonal transport: New paradigms for neurodegenerative disease.Bioessays2023;45:e2200138 PMCID:PMC10630968

[105] Everdingen KJ, van der Grond J, Kappelle LJ, Ramos LM, Mali WP. Diffusion-weighted magnetic resonance imaging in acute stroke.Stroke1998;29:1783-90

[106] Bang OY,Buck BH.Impact of collateral flow on tissue fate in acute ischaemic stroke.J Neurol Neurosurg Psychiatry2008;79:625-9 PMCID:PMC2702489

[107] Oppenheim C,Manaï R.Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging.Stroke2000;31:2175-81

[108] Demeestere J,Christensen S,Lansberg MG.Review of perfusion imaging in acute ischemic stroke: from time to tissue.Stroke2020;51:1017-24

[109] Greenberg SM,Cordonnier C.Cerebral microbleeds: a guide to detection and interpretation.Lancet Neurol2009;8:165-74

[110] Sorensen AG,Ostergaard L.Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time.Radiology1999;210:519-27

[111] Smith CJ,Gavin CM.Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome.BMC Neurol2004;4:2 PMCID:PMC331413

[112] Hofmeijer J.Ischemic cerebral damage: an appraisal of synaptic failure.Stroke2012;43:607-15

[113] Bustamante A,Vilar-Bergua A,Montaner J.Blood/Brain biomarkers of inflammation after stroke and their association with outcome: from C-reactive protein to damage-associated molecular patterns.Neurotherapeutics2016;13:671-84 PMCID:PMC5081112

[114] Goyal N,Chang JJ.Admission neutrophil-to-lymphocyte ratio as a prognostic biomarker of outcomes in large vessel occlusion strokes.Stroke2018;49:1985-7

[115] Li Y,Wang L.Values of lymphocyte-related ratios in predicting the clinical outcome of acute ischemic stroke patients receiving intravenous thrombolysis based on different etiologies.Front Neurol2025;16:1542889 PMCID:PMC12094968

[116] Telec M,Kazmierski R.Circulating CD4+, CD8+, and double-negative T cells in ischemic stroke and stroke-associated infection: a prospective case-control study.Front Cell Neurosci2025;19:1547905 PMCID:PMC12058799

[117] Fu Y,Anrather J.Immune interventions in stroke.Nat Rev Neurol2015;11:524-35 PMCID:PMC4851339

[118] Akhtar N,Kamran S.Characteristics and comparison of 32 COVID-19 and Non-COVID-19 ischemic strokes and historical stroke patients.J Stroke Cerebrovasc Dis2021;30:105435 PMCID:PMC7605738

[119] Hochrainer K.Stroke proteomics: from discovery to diagnostic and therapeutic applications.Circ Res2022;130:1145-66 PMCID:PMC9015233

[120] Li Q,Zhang Y.Using proteomic biomarkers to estimate acute ischaemic stroke onset time.Commun Med2025;5:183 PMCID:PMC12085557

[121] Li Q,Zhang Y.Metabolomic biomarkers could be molecular clocks in timing stroke onset.Sci Rep2025;15:21645 PMCID:PMC12217631

[122] Li X,Si X.The regulatory roles of circular RNAs via autophagy in ischemic stroke.Front Neurol2022;13:963508 PMCID:PMC9623297

[123] Lehmann ALCF,de Araújo MCM.Immune-inflammatory, coagulation, adhesion, and imaging biomarkers combined in machine learning models improve the prediction of death 1 year after ischemic stroke.Clin Exp Med2022;22:111-23

[124] Ruksakulpiwat S,Phianhasin L.A systematic review and meta-analysis assessing the accuracy of blood biomarkers for the diagnosis of ischemic stroke in adult and elderly populations.eNeuro2024;11:ENEURO.0302-24.2024

[125] American Heart Association. Public policy considerations of novel cardiovascular disease and stroke blood-based biomarkers; Dallas, TX: American Heart Association; 2024. Available from: https://www.heart.org/en/-/media/Files/About-Us/Policy-Research/Policy-Positions/Heart-Stroke-Research/Novel-CVD-Stroke-Biomarkers.pdf?sc_lang=en [Last accessed on 15 Aug 2025]

[126] Schöll M,Del Campo M.Challenges in the practical implementation of blood biomarkers for Alzheimer's disease.Lancet Healthy Longev2024;5:100630